1)Nouri K, et al : Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome(OHSS)-a retrospective case-control study. J Ovarian Res 7 : 54, 2014
2)Lussiana C, et al : Mutations and polymorphisms of the FSH receptor(FSHR)gene : clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 63 : 785-795, 2008
3)O'Brien TJ, et al : Association between the luteinizing hormone/chorionic gonadotropin receptor(LHCGR)rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod Biol Endocrinol 11 : 71, 2013
4)Practice Committee of the American Society for Reproductive Medicine : Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome : a guideline. Fertil Steril 106 : 1634-1647, 2016
5)厚生労働省 : 重篤副作用疾患別対応マニュアル 卵巣過剰刺激症候群(OHSS).2021 https://www.pmda.go.jp/files/000240131.pdf
6)Youssef MA, et al : Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev(10) : CD008046, 2014
7)Eshre Guideline Group on Ovarian Stimulation ; Bosch E, et al : ESHRE guideline : ovarian stimulation for IVF/ICSI. Hum Reprod Open 2020 : hoaa009, 2020
8)日本産科婦人科学会,他(編) : CQ 327 : 卵巣過剰刺激症候群(OHSS)の発症や重症化の予防は? 日本産科婦人科学会事務局,2020
9)D'Angelo A, et al : Coasting(withholding gonadotrophins)for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 5 : CD002811, 2017
10)日本生殖医学会(編) : CQ15 : 生殖補助医療に伴う卵巣過剰刺激症候群(OHSS)の発症や重症化の予防は? 介入治療はOHSSの予防に有効か? 日本生殖医学会,2021
11)Tang H, et al : Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 4 : CD008605, 2021
12)Zeng C, et al : The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment : a prospective cohort study. Arch Gynecol Obstet 300 : 223-233, 2019
13)Shrem G, et al : Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome. Reprod Biomed Online 39 : 433-438, 2019
14)Zhao J, et al : Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis. Reprod Health 17 : 181, 2020